Published in J Antimicrob Chemother on November 01, 1990
Vancomycin-resistant enterococci. Clin Microbiol Rev (2000) 5.61
Current perspectives on glycopeptide resistance. Clin Microbiol Rev (1995) 2.99
In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother (2004) 2.88
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother (2003) 1.69
In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother (1995) 1.50
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium. Antimicrob Agents Chemother (1994) 1.33
Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother (1992) 1.32
Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic. Antimicrob Agents Chemother (1995) 1.32
Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother (1999) 1.23
Bactericidal activity of ramoplanin against antibiotic-resistant enterococci. Antimicrob Agents Chemother (1992) 1.17
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci. Antimicrob Agents Chemother (1992) 1.08
Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother (1991) 1.05
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob Agents Chemother (1992) 0.98
In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci. Antimicrob Agents Chemother (1993) 0.97
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother (1996) 0.94
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.89
Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections. Antimicrob Agents Chemother (1992) 0.87
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Antimicrob Agents Chemother (1995) 0.86
Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother (1993) 0.78
Different broth dilution procedures generate different apparent MICs for ramoplanin. J Antimicrob Chemother (1994) 0.75
Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot (Tokyo) (1978) 3.62
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic. J Antimicrob Chemother (1999) 1.83
Inhibition of viral replication in vitro by antiviral-treated amniotic membrane. Possible use of amniotic membrane as drug-delivering tool. Br J Ophthalmol (2010) 1.46
Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action. J Antibiot (Tokyo) (1975) 1.43
[Recommendations on hypertension in children: the CHI/d project]. Pediatr Med Chir (2005) 1.42
Helicobacter pylori potentiates histamine release from serosal rat mast cells in vitro. Dig Dis Sci (1993) 1.40
Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol (2000) 1.33
Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy. J Clin Microbiol (1984) 1.21
A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria. J Antimicrob Chemother (1988) 1.20
A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot (Tokyo) (1984) 1.20
Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies. J Antibiot (Tokyo) (1975) 1.14
Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization. J Antibiot (Tokyo) (1975) 1.14
Structure and mechanism of action of teicoplanin. J Hosp Infect (1986) 1.12
Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet (2008) 1.11
Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol (1996) 1.11
Gardimycin, a new antibiotic inhibiting peptidoglycan synthesis. Antimicrob Agents Chemother (1977) 1.10
The effect of phytohaemagglutinin on the metabolism and gamma-globulin synthesis of human lymphocytes. Biochim Biophys Acta (1966) 1.05
Improved identification of Staphylococcus aureus using a new agglutination test. Results of an international study. APMIS (1993) 1.04
Synthesis and biological activity of some derivatives of rifamycin P. J Med Chem (1990) 1.01
Members of the genus Actinoplanes and their antibiotics. Annu Rev Microbiol (1979) 1.00
In-vitro activity of nisin against clinical isolates of Clostridium difficile. J Chemother (2004) 0.97
Nontuberculous mycobacteria in hospital water systems: application of HPLC for identification of environmental mycobacteria. J Water Health (2003) 0.96
Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance. J Prev Med Hyg (2011) 0.94
In vitro Protein Synthesis by Plastids of Phaseolus vulgaris. III. Formation of Lamellar and Soluble Chloroplast Protein. Plant Physiol (1968) 0.93
In vitro Protein Synthesis by Plastids of Phaseolus vulgaris. II. The Probable Relation Between Ribonuclease Insensitive Amino Acid Incorporation and the Presence of Intact Chloroplasts. Plant Physiol (1968) 0.92
Age-related changes in the prevalence of precipitating antibodies to BK virus in infants and children. J Med Microbiol (1982) 0.92
Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol (1990) 0.91
Emergency department syndromic surveillance system for early detection of 5 syndromes: a pilot project in a reference teaching hospital in Genoa, Italy. J Prev Med Hyg (2008) 0.91
Reflux-related gastric mucosal injury is associated with increased mucosal histamine content in humans. Gastroenterology (1993) 0.88
Influence of protein and energy intakes on body composition of formula-fed preterm infants after term. J Pediatr Gastroenterol Nutr (2008) 0.87
Isolation of nuclei from Euglena gracilis. Biochim Biophys Acta (1969) 0.87
Comparative efficacy of a single 400 mg dose of albendazole or mebendazole in the treatment of nematode infections in children. Trop Geogr Med (1993) 0.86
Detection of Helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody. Ital J Gastroenterol (1992) 0.85
Gardimycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies. J Antibiot (Tokyo) (1976) 0.85
Biometrical implications of factorial experiments for the study of lymphocyte mitogenic response. J Immunol Methods (1977) 0.85
Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13 - valent polysaccharide conjugate vaccine. Minerva Med (2014) 0.84
Outbreak of Clostridium difficile diarrhoea in an orthopaedic unit: evidence by phage-typing for cross-infection. J Hosp Infect (1989) 0.84
Gastric mucosal histamine storing cells. Evidence for different roles of mast cells and enterochromaffin-like cells in humans. Dig Dis Sci (1995) 0.84
The use of rifampicin in staphylococcal infections--a review. J Antimicrob Chemother (1984) 0.84
Microflora persistence on duodenojejunal flat or normal mucosa in time after a meal in children. Physiol Behav (1996) 0.84
Helicobacter pylori and duodenal ulcer: evidence for a histamine pathways-involving link. Am J Gastroenterol (1996) 0.83
Oral lesions among HIV-infected hemophiliacs. A study of 54 patients. Haematologica (1994) 0.83
Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. J Clin Pathol (1998) 0.82
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects. J Chemother (1989) 0.81
Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains. Acta Neuropathol (2001) 0.81
Human herpesvirus 6-associated limbic encephalitis in adult recipients of unrelated umbilical cord blood transplantation. Bone Marrow Transplant (2008) 0.81
Multicenter evaluation of the new HIV DUO assay for simultaneous detection of HIV antibodies and p24 antigen. New Microbiol (2000) 0.81
Diffusion of teicoplanin and vancomycin in agar. Diagn Microbiol Infect Dis (1992) 0.80
Cytomegalovirus encephalitis in a non-immunocompromised patient: CSF diagnosis by in situ hybridization cells. Acta Neurol Scand (1991) 0.80
Rifampin therapy for brucellosis, flavobacterium meningitis, and cutaneous leishmaniasis. Rev Infect Dis (1983) 0.79
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia. J Trop Med Hyg (1990) 0.79
Differential effect of phosphate starvation on synthetic and division rates of Euglena. Exp Cell Res (1971) 0.79
Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone. J Clin Pathol (1997) 0.79
In vitro activity of rifaximin and rifampicin against some anaerobic bacteria. Chemioterapia (1984) 0.79
Apical hypertrophic cardiomyopathy of "Japanese type" in a Western European person. Am J Cardiol (1986) 0.78
[A cross-sectional survey on childhood immunization coverage and reasons of non-compliance in Lazio Region, Italy (2007)]. Ann Ig (2009) 0.78
The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1. Thromb Haemost (1989) 0.77
High-level aminoglycoside resistance among enterococci isolated from blood cultures. J Antimicrob Chemother (1992) 0.77
Intrathecal synthesis of anti-HIV antibodies in AIDS patients. J Neurol Sci (1990) 0.77
Vertical transmission of HCV. Acta Obstet Gynecol Scand (1998) 0.77
Risk of HIV infection on patients and staff of two dialysis centers: seroepidemiological findings and prevention trends. Eur J Epidemiol (1988) 0.76
Synthesis and biological activity of some 2-aminoimidazoles. Arzneimittelforschung (1977) 0.76
Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma (2006) 0.76
Cloning of a DNA region of Actinoplanes teichomyceticus conferring teicoplanin resistance. FEBS Lett (1989) 0.76
Strongyloides stercoralis: ultrastructural study of newly hatched larvae within human duodenal mucosa. J Clin Pathol (2000) 0.76
Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. J Clin Pathol (1998) 0.76
A42867, a novel glycopeptide antibiotic. J Antibiot (Tokyo) (1989) 0.75
Betalactam therapy and intestinal flora. J Chemother (1995) 0.75
Multiple bilateral fibromas of the pleura. Thorax (1973) 0.75
Clinical aspects and microbiology of HIV-associated periodontal lesions. Minerva Stomatol (1993) 0.75
Capillary zone electrophoresis of polymerase chain reaction-amplified DNA fragments in polymer networks: the case of GATT microsatellites in cystic fibrosis. Electrophoresis (1994) 0.75
Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study. J Chemother (1992) 0.75
Treatment of isosporiasis with combined albendazole and ornidazole in patients with AIDS. AIDS (1996) 0.75
The Italian experience of quality control in microbiology. Quad Sclavo Diagn (1984) 0.75
Evaluation of six different agglutination methods for rapid identification of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1989) 0.75
A new vision of leadership. Deep spirituality moves leaders to effectively serve community. Health Prog (1995) 0.75
[Quality control in microbiology]. Quad Sclavo Diagn (1982) 0.75
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region, Bolivia. Boll Ist Sieroter Milan (1989) 0.75
[Pulmonary hydatidosis in the child. Different initial forms]. Arch Argent Pediatr (1968) 0.75
In vitro antibacterial activity of imipenem and other agents against gram-negative and gram-positive strains isolated from clinical specimens. G Ital Chemioter (1989) 0.75
[Intestinal microbial pathology in AIDS. A clinical case series]. Recenti Prog Med (1991) 0.75
[Jejunal microflora in children with flat mucosa and normal mucosa]. Minerva Pediatr (1986) 0.75
[Comparative activity of macrolide-glucoside antibiotics on recently isolated strains of aerobic and anaerobic bacteria "in vitro"]. G Ital Chemioter (1982) 0.75
In vitro antimicrobial sensitivity of staphylococci isolated in the Santa Cruz region of Bolivia. Boll Ist Sieroter Milan (1989) 0.75
[The comparative evaluation of the main conventional and automated techniques for "in vitro" bacterial sensitivity testing to chemoantibiotics (author's transl)]. Quad Sclavo Diagn (1979) 0.75
[Intralobar pulmonary sequestration]. Prensa Med Argent (1971) 0.75
[Blood culture results from 1967 to 1975 and drug sensitivity of bacteria isolated by blood culture in the last three years (1974-1976) (author's transl)]. Ann Sclavo (1978) 0.75
[Induction of bacterial translocation in rats with minimal doses of endotoxin]. Minerva Anestesiol (1993) 0.75
[Comparison of the results of antibiotic sensitivity tests made with the ABAC method and the agar diffusion method]. Quad Sclavo Diagn (1981) 0.75
Prevalence of antibody to hepatitis A virus in the Santa Cruz region of Bolivia. J Trop Med Hyg (1989) 0.75
[Quality control on antibiotic sensitivity tests: preliminary trials (author's transl)]. Quad Sclavo Diagn (1979) 0.75
[HIV infection and lesions of the oral cavity: clinical and therapeutic aspects]. G Clin Med (1988) 0.75
[Comparison of direct and standardized disk diffusion susceptibility testing of urine and other clinical specimens (author's transl)]. Quad Sclavo Diagn (1979) 0.75
[Proctocolitis caused by Schistosoma mansoni in AIDS. A clinical and immunohistochemical study of a case]. Recenti Prog Med (1991) 0.75
[Isosporiasis and sarcocystosis. The current findings]. Recenti Prog Med (1992) 0.75
[Sensitivity tests on bacterial strains from respiratory tract: comparison between direct and on isolated strains antimicrobial disc susceptibility test (author's transl)]. Ann Sclavo (1977) 0.75